A study published in the Journal of the American Medical Association found that users of semaglutide, the active ingredient in Wegovy, face a threefold increased risk of stomach paralysis compared to those using oral weight loss drugs
But their power comes from this deep biological interaction
It's especially beneficial for individuals with obesity or those who have certain weight-related health conditions, such as: During your initial consultation at Health Meets Wellness, our team will assess your health history and discuss whether GLP-1 treatment is right for you
14 Furthermore, GLP-1 RAs reportedly induce weight loss by reducing appetite and this satiety-promoting effect has recently attracted significant interest
The apparent absence of the bone mineral density preservation effect seen with liraglutide in MC4R -deficient patients, unlike in common obesity, underscores the need for vigilant bone health assessment and potential adjunctive interventions in this group
These statements include projections and estimates regarding the marketing and other potential of the product, or regarding potential future revenues from the product
